Arkadios Wealth Advisors Acquires Shares of 6,851 Ryan Specialty Holdings Inc. $RYAN

Arkadios Wealth Advisors acquired a new stake in Ryan Specialty Holdings Inc. (NYSE:RYAN) in the second quarter, Holdings Channel reports. The institutional investor acquired 6,851 shares of the company’s stock, valued at approximately $466,000.

Several other institutional investors and hedge funds have also recently modified their holdings of the business. Jennison Associates LLC increased its stake in shares of Ryan Specialty by 1.4% in the 2nd quarter. Jennison Associates LLC now owns 1,000,807 shares of the company’s stock valued at $68,045,000 after purchasing an additional 13,655 shares in the last quarter. AlphaQuest LLC increased its position in shares of Ryan Specialty by 2,138.6% in the second quarter. AlphaQuest LLC now owns 3,134 shares of the company’s stock valued at $213,000 after buying an additional 2,994 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. increased its position in shares of Ryan Specialty by 9.7% in the second quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,353,520 shares of the company’s stock valued at $92,026,000 after buying an additional 120,214 shares in the last quarter. Asset Management One Co. Ltd. purchased a new stake in shares of Ryan Specialty in the second quarter valued at approximately $1,636,000. Finally, Ethic Inc. increased its position in shares of Ryan Specialty by 58.0% in the second quarter. Ethic Inc. now owns 7,683 shares of the company’s stock valued at $519,000 after buying an additional 2,819 shares in the last quarter. Hedge funds and other institutional investors own 84.82% of the company’s stock.

Insider Buying and Selling at Ryan Specialty

In other news, Chairman Patrick G. Ryan purchased 276,634 shares of the company’s stock in a transaction dated Friday, September 12th. The stock was acquired at an average price of $51.84 per share, with a total value of $14,340,706.56. Following the purchase, the chairman directly owned 13,699,959 shares in the company, valued at approximately $710,205,874.56. This represents a 2.06% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. 52.21% of the stock is currently owned by company insiders.

Ryan Specialty Price Performance

RYAN stock opened at $55.02 on Wednesday. The company has a debt-to-equity ratio of 2.72, a current ratio of 1.00 and a quick ratio of 1.01. The business has a 50 day simple moving average of $54.36 and a 200-day simple moving average of $61.64. The firm has a market capitalization of $14.51 billion, a PE ratio of 119.60, a price-to-earnings-growth ratio of 1.48 and a beta of 0.62. Ryan Specialty Holdings Inc. has a 1 year low of $50.08 and a 1 year high of $77.16.

Ryan Specialty (NYSE:RYAN) last issued its earnings results on Thursday, October 30th. The company reported $0.47 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.47. Ryan Specialty had a return on equity of 47.93% and a net margin of 7.61%.The company had revenue of $754.58 million during the quarter, compared to analysts’ expectations of $742.35 million. During the same period in the prior year, the business earned $0.41 EPS. The firm’s quarterly revenue was up 24.8% on a year-over-year basis. Equities research analysts anticipate that Ryan Specialty Holdings Inc. will post 2.29 earnings per share for the current fiscal year.

Ryan Specialty Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 25th. Investors of record on Tuesday, November 11th will be issued a $0.12 dividend. The ex-dividend date of this dividend is Monday, November 10th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.9%. Ryan Specialty’s dividend payout ratio is currently 104.35%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on RYAN. JPMorgan Chase & Co. reduced their price objective on shares of Ryan Specialty from $64.00 to $63.00 and set an “underweight” rating for the company in a research report on Thursday, October 9th. Wall Street Zen raised shares of Ryan Specialty from a “sell” rating to a “hold” rating in a research note on Sunday, August 3rd. Keefe, Bruyette & Woods cut their target price on shares of Ryan Specialty from $73.00 to $65.00 and set an “outperform” rating for the company in a research note on Monday. Weiss Ratings reissued a “hold (c-)” rating on shares of Ryan Specialty in a research note on Wednesday, October 8th. Finally, The Goldman Sachs Group cut their price objective on Ryan Specialty from $71.00 to $63.00 and set a “buy” rating for the company in a research note on Friday. One analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $68.54.

Ryan Specialty Company Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.